Febbo Phillip G. 4

What Happened
Phillip G. Febbo, Chief Scientific and Medical Officer of Veracyte, had 3,730 shares of Veracyte (VCYT) withheld to satisfy tax withholding obligations related to the vesting of restricted stock units. The withholding was reported as a disposition on Form 4 at $47.80 per share, for a notional value of $178,294. This action represents tax withholding on an equity award, not an open-market sale.

Key Details

• Transaction date: June 2, 2026; Filing date: June 4, 2026 (filed within the typical two-business-day window).
• Reported code: F (payment of exercise price or tax liability via share withholding).
• Shares withheld/disposed: 3,730 at $47.80 each; total value reported $178,294.
• Footnote: F1 clarifies these shares were withheld to satisfy tax obligations on RSU vesting and "does not represent a sale."
• Shares owned after the transaction: Not disclosed in the provided filing.

Context
This was a routine tax-withholding event tied to RSU vesting (a common way companies satisfy withholding without a cash payment by the insider). Because the shares were withheld for taxes rather than sold on the open market, this filing should not be read as an indication of the insider reducing or adding to their net position through a market transaction.